Prakash Bhuyan

1.1k total citations
28 papers, 759 citations indexed

About

Prakash Bhuyan is a scholar working on Epidemiology, Microbiology and Hepatology. According to data from OpenAlex, Prakash Bhuyan has authored 28 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 10 papers in Microbiology and 8 papers in Hepatology. Recurrent topics in Prakash Bhuyan's work include Hepatitis B Virus Studies (10 papers), Bacterial Infections and Vaccines (9 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). Prakash Bhuyan is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Bacterial Infections and Vaccines (9 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). Prakash Bhuyan collaborates with scholars based in United States, Canada and France. Prakash Bhuyan's co-authors include Katalin Karikó, John Capodici, Drew Weissman, John M. Lubinski, Harvey M. Friedman, Geoffrey W. Butcher, Houping Ni, K F Lindahl, LOUIS L. YOUNG and Jason Martin and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Scientific Reports.

In The Last Decade

Prakash Bhuyan

28 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prakash Bhuyan United States	12	375	254	251	157	118	28	759
Claire Entwisle United Kingdom	12	139 0.4×	188 0.7×	256 1.0×	50 0.3×	65 0.6×	21	550
Peter C. Angeletti United States	17	427 1.1×	110 0.4×	437 1.7×	97 0.6×	89 0.8×	38	975
Robert Jackson Canada	14	195 0.5×	137 0.5×	213 0.8×	34 0.2×	86 0.7×	25	521
Motohide Ichino Japan	15	248 0.7×	448 1.8×	141 0.6×	34 0.2×	24 0.2×	23	792
Qiang Ruan China	19	325 0.9×	129 0.5×	691 2.8×	54 0.3×	206 1.7×	83	872
Marisa Nia Madison United States	11	607 1.6×	191 0.8×	97 0.4×	58 0.4×	162 1.4×	14	831
Agnetha Josefsson Sweden	12	230 0.6×	236 0.9×	794 3.2×	159 1.0×	62 0.5×	16	1.0k
Jesús Colino United States	13	206 0.5×	347 1.4×	171 0.7×	79 0.5×	51 0.4×	26	591
Joanna L. Parish United Kingdom	21	561 1.5×	178 0.7×	590 2.4×	24 0.2×	164 1.4×	41	1.2k
Andreas Towarowski Germany	6	176 0.5×	1.2k 4.7×	145 0.6×	65 0.4×	37 0.3×	6	1.4k

Countries citing papers authored by Prakash Bhuyan

Since Specialization

Citations

This map shows the geographic impact of Prakash Bhuyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Bhuyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Bhuyan more than expected).

Fields of papers citing papers by Prakash Bhuyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Bhuyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Bhuyan. The network helps show where Prakash Bhuyan may publish in the future.

Co-authorship network of co-authors of Prakash Bhuyan

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Bhuyan. A scholar is included among the top collaborators of Prakash Bhuyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Bhuyan. Prakash Bhuyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schäfer, Alexander, Peter Sagelsdorff, Björn Hock, et al.. (2024). HPLC–MS/MS-based quantification of human monoclonal antibodies targeting SARS-CoV-2 in the presence of endogenous SARS-CoV-2 antibodies in human serum. Analytical and Bioanalytical Chemistry. 416(19). 4383–4396. 1 indexed citations

Moullan, Norman, Moetaz Albizem, Björn Hock, et al.. (2024). A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies. Infectious Diseases and Therapy. 13(1). 173–187. 4 indexed citations

Cohen, Taylor S., Elizabeth J. Kelly, Sven Nylander, et al.. (2022). Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination. Scientific Reports. 12(1). 7961–7961. 5 indexed citations

Laffan, Michael, et al.. (2022). Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations. Vaccine. 40(38). 5585–5593. 6 indexed citations

Krieger, Diane, Robert J. Samuels, Albert J. Sylvester, et al.. (2019). Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population. Human Vaccines & Immunotherapeutics. 16(6). 1404–1412. 6 indexed citations

Senders, Shelly, Prakash Bhuyan, Qin Jiang, et al.. (2016). Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine. The Pediatric Infectious Disease Journal. 35(5). 548–554. 34 indexed citations

Muse, Derek, Prakash Bhuyan, Judith Absalon, et al.. (2016). A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents. The Pediatric Infectious Disease Journal. 35(6). 673–682. 31 indexed citations

Reiner, David, Prakash Bhuyan, Joseph Eiden, et al.. (2015). Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers. Vaccine. 34(6). 809–813. 11 indexed citations

Bhuyan, Prakash, Joseph Eiden, Thomas R. Jones, et al.. (2014). 1081Immunogenicity of Human Papilloma Vaccine Coadministered with an Investigational Bivalent rLP2086 Vaccine Against Meningococcal Serogroup B in Healthy Adolescents. Open Forum Infectious Diseases. 1(suppl_1). S317–S318. 4 indexed citations

10.

Gilbert, Christopher L., Jon E. Stek, Giuseppe Villa, et al.. (2014). Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients. Vaccine. 32(48). 6521–6526. 8 indexed citations

11.

Halperin, Scott A., Bruce Tapiéro, Marc Dionne, et al.. (2013). Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 33(1). 73–80. 14 indexed citations

12.

Tapiéro, Bruce, Scott A. Halperin, William Meekison, et al.. (2012). Safety and Immunogenicity of a Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 32(1). 54–61. 14 indexed citations

13.

Lee, Andrew W., Timo Vesikari, Christopher L. Gilbert, et al.. (2011). Immunogenicity and safety of a Haemophilus influenzae B (Hib)–hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants. Vaccine. 29(45). 7942–7948. 2 indexed citations

14.

Vesikari, Timo, Jason Martin, Charles Liss, et al.. (2011). Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants. The Pediatric Infectious Disease Journal. 30(7). e109–e113. 5 indexed citations

15.

Díaz‐Mitoma, Francisco, Scott A. Halperin, Bruce Tapiéro, et al.. (2010). Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age. Vaccine. 29(6). 1324–1331. 8 indexed citations

16.

Díez‐Domingo, Javier, et al.. (2010). A RANDOMIZED, MULTICENTER, OPEN-LABEL CLINICAL TRIAL TO ASSESS THE ANAMNESTIC IMMUNE RESPONSE 4 TO 8 YEARS AFTER A PRIMARY HEPATITIS B VACCINATION SERIES. The Pediatric Infectious Disease Journal. 29(10). 972–974. 4 indexed citations

17.

Bhuyan, Prakash. (2009). Safety and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured by a Modified Process in Renal Predialysis and Dialysis Patients. 1 indexed citations

18.

Damme, Pierre Van, et al.. (2009). Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Human Vaccines. 5(2). 92–97. 24 indexed citations

19.

Karikó, Katalin, Prakash Bhuyan, John Capodici, & Drew Weissman. (2004). Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3. The Journal of Immunology. 172(11). 6545–6549. 351 indexed citations

20.

Bhuyan, Prakash, LOUIS L. YOUNG, K F Lindahl, & Geoffrey W. Butcher. (1997). Identification of the rat maternally transmitted minor histocompatibility antigen. The Journal of Immunology. 158(8). 3753–3760. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact